Literature DB >> 16996738

Multiple sclerosis: an infectious syndrome involving Chlamydophila pneumoniae.

Charles W Stratton1, David B Wheldon.   

Abstract

The concept of autoimmune myelinopathy as the primary pathology in multiple sclerosis (MS) is problematic. Vasculitis is seen in the MS brain, both within lesions and in adjacent normal-appearing white matter. The first observation in acute relapse is the sudden, orderly death of oligodendrocytes; inflammatory removal of unsupported myelin seems to be a secondary process. An alternative explanation for these findings is that oligodendrocyte infection might trigger an inflammatory response. Many pathogens, including Chlamydophila (Chlamydia) pneumoniae, have been associated with MS. MS might be an infectious syndrome in which C. pneumoniae has a role in a subset of patients. Mechanisms by which such a cryptic infection could engender relapsing-remitting and, ultimately, progressive disease patterns are discussed.

Entities:  

Mesh:

Year:  2006        PMID: 16996738     DOI: 10.1016/j.tim.2006.09.002

Source DB:  PubMed          Journal:  Trends Microbiol        ISSN: 0966-842X            Impact factor:   17.079


  12 in total

1.  The impact of glial activation in the aging brain.

Authors:  Aileen M Lynch; Kevin J Murphy; Brian F Deighan; Julie-Ann O'Reilly; Yuri K Gun'ko; Thelma R Cowley; Rodrigo E Gonzalez-Reyes; Marina A Lynch
Journal:  Aging Dis       Date:  2010-09-04       Impact factor: 6.745

2.  Enhanced Direct Major Histocompatibility Complex Class I Self-Antigen Presentation Induced by Chlamydia Infection.

Authors:  Erik D Cram; Ryan S Simmons; Amy L Palmer; William H Hildebrand; Daniel D Rockey; Brian P Dolan
Journal:  Infect Immun       Date:  2015-11-23       Impact factor: 3.441

3.  Chlamydophila pneumoniae Infection and Its Role in Neurological Disorders.

Authors:  Carlo Contini; Silva Seraceni; Rosario Cultrera; Massimiliano Castellazzi; Enrico Granieri; Enrico Fainardi
Journal:  Interdiscip Perspect Infect Dis       Date:  2010-02-21

4.  Serum DNA motifs predict disease and clinical status in multiple sclerosis.

Authors:  Julia Beck; Howard B Urnovitz; Marina Saresella; Domenico Caputo; Mario Clerici; William M Mitchell; Ekkehard Schütz
Journal:  J Mol Diagn       Date:  2010-03-12       Impact factor: 5.568

5.  Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis.

Authors:  Yun Kyung Lee; Juscilene S Menezes; Yoshinori Umesaki; Sarkis K Mazmanian
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-26       Impact factor: 11.205

6.  Isolation of Chlamydia pneumoniae from serum samples of the patients with acute coronary syndrome.

Authors:  Ivan M Petyaev; Nayilia A Zigangirova; Alexey M Petyaev; Ulia P Pashko; Lubov V Didenko; Elena U Morgunova; Yuriy K Bashmakov
Journal:  Int J Med Sci       Date:  2010-06-10       Impact factor: 3.738

Review 7.  Individuality, phenotypic differentiation, dormancy and 'persistence' in culturable bacterial systems: commonalities shared by environmental, laboratory, and clinical microbiology.

Authors:  Douglas Kell; Marnie Potgieter; Etheresia Pretorius
Journal:  F1000Res       Date:  2015-07-01

8.  A novel inhibitor of Chlamydophila pneumoniae protein kinase D (PknD) inhibits phosphorylation of CdsD and suppresses bacterial replication.

Authors:  Dustin L Johnson; Chris B Stone; David C Bulir; Brian K Coombes; James B Mahony
Journal:  BMC Microbiol       Date:  2009-10-14       Impact factor: 3.605

9.  Qualitative and quantitative detection of Chlamydophila pneumoniae DNA in cerebrospinal fluid from multiple sclerosis patients and controls.

Authors:  Yi-Wei Tang; Subramaniam Sriram; Haijing Li; Song-yi Yao; Shufang Meng; William M Mitchell; Charles W Stratton
Journal:  PLoS One       Date:  2009-04-09       Impact factor: 3.240

10.  The Chlamydia outer membrane protein OmcB is required for adhesion and exhibits biovar-specific differences in glycosaminoglycan binding.

Authors:  Katja Moelleken; Johannes H Hegemann
Journal:  Mol Microbiol       Date:  2007-12-11       Impact factor: 3.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.